MedTrace Logo

Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department

NCT00590317 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2014-05-19

Study results available
· View outcomes & findings →

Summary

This study will compare the effect of prochlorperazine and ondansetron for the treatment of nausea and vomiting in the emergency department.

Conditions

  • Nausea and Vomiting

Interventions

DRUG

Prochlorperazine

Patients receiving Prochlorperazine

DRUG

Ondansetron

Patients receiving Ondansetron

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • John Patka, PharmD · Grady Memorial Hospital

  • Daniel T Wu, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00590317 on ClinicalTrials.gov